| Literature DB >> 35684500 |
Jenifer da Silva Mendonça1, Rita de Cássia Avellaneda Guimarães1, Verônica Assalin Zorgetto-Pinheiro1, Carolina Di Pietro Fernandes2, Gabriela Marcelino1, Danielle Bogo1, Karine de Cássia Freitas1, Priscila Aiko Hiane1, Elaine Silva de Pádua Melo1,2,3, Marcelo Luiz Brandão Vilela3, Valter Aragão do Nascimento1,2,3.
Abstract
Antioxidants have drawn the attention of the scientific community due to being related to the prevention of various degenerative diseases. The antioxidant capacity has been extensively studied in vitro, and different methods have been used to assess its activity. However, the main issues related to studying natural antioxidants are evaluating whether these antioxidants demonstrate a key role in the biological system and assessing their bioavailability in the organism. The majority of outcomes in the literature are controversial due to a lack of method standardization and their proper application. Therefore, this study aims to compile the main issues concerning the natural antioxidant field of study, comparing the most common in vitro methods to evaluate the antioxidant activity of natural compounds, demonstrating the antioxidant activity in biological systems and the role of the main antioxidant enzymes of redox cellular signaling and explaining how the bioavailability of bioactive compounds is evaluated in animal models and human clinical trials.Entities:
Keywords: antioxidant; antioxidant assay; bioactive compounds; in vitro models; in vivo models; secondary metabolites
Mesh:
Substances:
Year: 2022 PMID: 35684500 PMCID: PMC9182375 DOI: 10.3390/molecules27113563
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Advantages and disadvantages of DPPH, ABTS, ORAC and FRAP, TRAP methods.
| Method | Advantages | Disadvantages |
|---|---|---|
| DPPH | Easy procedure | EC50 concept could be hard to interpret |
| ABTS | Low cost | Now standardized, which difficult comparison among results |
| ORAC | Once the method is standardized allows comparison | Expensive |
| FRAP | Used in samples of plant origin. | Uses high volume of reagent. |
| TRAP | It is sensitive to all antioxidants present in the sample. | It is a complex and time-consuming technique that requires a high degree of knowledge and experience. |
Adapted from Zulueta et al. [138].
Figure 1Integration of enzymes that participate in the antioxidant defense of the enzymatic antioxidant system. Note: During the processes of aerobic metabolism, reactive oxygen species are formed, such as superoxide (O²−) radicals. The enzymatic system is the first to act to prevent the accumulation of these molecules and their intermediates. Superoxide dismutase (SOD) catalyzes the dismutation of the superoxide radical into hydrogen peroxide (H2O2), which despite not being a free radical, due to the absence of unpaired electrons in the last layer, H2O2 is an oxygen metabolite that participates in the Fenton and Haber–Weiss reaction and results in hydrogen peroxide (OH−)production, responsible for major cellular damage. To avoid this, other enzymes act in conjunction with SOD, namely catalase (CAT) and glutation peroxidase (GPx). CAT catalyzes the reduction of H2O2 to water (H2O) and oxygen (O2). GPx catalyzes the reduction of H2O2 to H2O at the cost of converting reduced glutathione (GSH) to glutathione disulfide (GSSG). In the oxidation process, glutathione reductase (GR) regenerate GSH in the presence of NADPH (H+) as a cofactor. The integrated action of these enzymes is responsible for protecting cells from oxidative damage.
Summary of studies on bioavailability and action of polyphenols, vitamins and carotenoids using animal models or clinical trials.
| Compound | Study Design | Bioavailability | Assays | Results | Related Antioxidant | Reference |
|---|---|---|---|---|---|---|
| Guaraná powdered seed ( | Humans (healthy overweight adults) | Detected 1 h after intake and remained after plasma clearance (plasma HPLC) | ORAC | ↑ORAC | Guaraná is a rich source of bioavailable catechins and contributes to reducing the oxidative stress parameters of clinically health overweight individuals by direct antioxidant action and up-regulation of antioxidant enzymes. | Yonekura et al. (2016) [ |
| Single dose (3 g/90 mg catechins and 60 mg epicatechins equivalent) daily for 15 days | SOD/CAT/GPx activities | ↑CAT/GPx | ||||
| Blood samples: overnight-fasting and 1 h after intake | Ex vivo LDL oxidation/H2O2 induced DNA damage in lymphocytes (Comet Assay) | ↓LDL oxidation (only in the first day of study) | ||||
| Green (GT) and Black Tea (BT) (commercially acquired) | Male Wistar rats (n = 18) | Not evaluated | Drug metabolizing enzymes activity (hepatic and pulmonary) | ↑P450 (CYP) 1A1 (hep) | Feeding both tea drinks to rats modulated drug metabolizing enzymes at a transcriptional level and reduced oxidative stress in the liver and lungs, but green tea was more effective in reducing oxidative stress. Their possible interactions with drugs or toxic compounds should be taken into account. | Yao et al. (2014) [ |
| Ad libitum with food and as water replacement for 5 weeks | GSH, GSSG and GSH/GSSG ratio | ↓[GSH] (hep/pulm) | ||||
| Blood and tissue (liver and lungs) samples after being euthanized | GPx and GSR | |||||
| DNA-binding activity of nuclear factors | ||||||
| Coffee (caffeic and ferulic acids) | Humans (n = 20) | Detected 1 h after intake (plasma HPLC) | ORAC | ↑ORAC | Lara-Guzmán et al. (2016) [ | |
| FRAP/TRAP | ↑FRAP/↔TRAP | The experiments on plasma with caffeic and ferulic acids showed a significant increase in the antioxidant activity as well as delay of LDL oxidation. | ||||
| After acute consumption (1 h/400 mL) | Ex vivo LDL oxidation | ↓LDL oxidation | ||||
| Vitamin C supplementation | Male Sprague Dawley rats ( | Detected in plasma and cerebral tissue (spectrophotometry) | Histopathology | Diabetic state: ↑infarct volume and edema | Daily intake of ascorbic acid attenuates the exacerbation of cerebral ischemic injury in a diabetic state, which may be attributed to anti-apoptotic and anti-inflammatory effects via the improvement of augmented oxidative stress in the brain. Ascorbic acid supplementation may protect endothelial function against the exacerbated ischemic oxidative injury and improve its transport through SVCT2 in the cortex. | Iwata et al. (2014) [ |
| Streptozotocin-induced type 1 diabetes | IHC (SVCT2, GLUT-1, cleaved caspase-3, TNF-α, IL-1β | ↓cleaved caspase-3 | ||||
| 100 mg/kg of ascorbic acid (gavage) for 2 weeks before cerebral ischemia-reperfusion protocol | PCR (SVCT2 and GLUT1) | ↑SVCT2 (neurons and endothelial cells) | ||||
| Cerebral ischemia-reperfusion (infarct induction) | Superoxide production | ↓superoxide radical | ||||
| Multivitamin supplementation (vit. C + vit. E + sodium selenite + β-carotene) | Female Sprague Dawley rats ( | Not evaluated | Histopathology | ↓honeycomb-like injury | The antioxidant combination protected lung tissue against damage by enhancing biochemical parameters and pulmonary edema, while no significant effect on protection of pulmonary inflammation was observed. The antioxidant vitamin supplementation with selenium can be used in the prevention of acute lung injury. | Bayrak et al. (2016) [ |
| Vitamin C (100 mg/kg/day), vitamin E (100 mg/kg/day), sodium selenite (0.2 mg/kg/day and β-carotene (15 mg/kg/day) via gavage for 3 days before the injury protocol | ||||||
| D-galactosamine-induced (DGaIN) acute lung injury | GSH/GPx/PON | ↑GSH/GPx/PON | ||||
| LPO (MDA) | ↓LPO | |||||
| Multivitamin supplementation (vit. C + vit. E + sodium selenite + β-carotene) | Female Sprague Dawley rats | Not evaluated | Histopathology | ↓edema | The combination of antioxidants suppressed histopathological changes in the liver and biochemical parameters in D-GaIN-induced hepatotoxicity rats. The antioxidant vitamin supplementation with selenium can be used in the prevention of acute hepatotoxicity. | Catal et al. (2017) [ |
| Vitamin C (100 mg/kg/day), vitamin E (100 mg/kg/day), sodium selenite (0.2 mg/kg/day and β-carotene (15 mg/kg/day) via gavage for 3 days before the injury protocol | Blood GSH/CAT | ↑blood GSH and CAT | ||||
| D-galactosamine-induced (DGaIN) acute liver injury | LPO (MDA) | ↓hepatic LPO | ||||
| Histopathology | ||||||
| Carotenoids derived from microalgal biomass ( | Male Wistar rats ( | Detected in plasma after 2 h, in the liver after 4 h and in the eyes after 6 h (HPLC/LC-MS) | Plasma and hepatic SOD, CAT, peroxidase and lipid peroxidation (TBARS) | ↑plasma and hepatic SOD, CAT and peroxidase | Rao et al. (2013) [ | |
| Sigle dose of microalgal biomass (200 µM equivalent of β-carotene, astaxanthin and lutein) via gavage for 15 days | These results indicate that the astaxanthin from | |||||
| Fucoxanthin (FUCO) solubilized in glycolipid (GL) and absorbed from chitosan nanogels (NG) | Rat model | Plasma FUCO (HPLC). | CAT/GST/SODLipid peroxidation (TBARS) | ↑CAT/GST/SOD | The advantage of CS-NGs + GL for improved FUCO bioavailability via passive and active transport through PPARc mediated SRB1 activation was demonstrated. Elevated plasma and tissue levels of FUCO in these groups could be the reason for a higher activity of antioxidant enzymes and lower lipid peroxides. | Ravi and Baskaram (2017) [ |
| Single dose study: 48 h | Plasma FUCO (HPLC) after dietary feeding: | PPARγ/SRB1 | ↑PPARγ/SRB1(FUCO and GL had an agonist action) | |||
| Lycopene | Murine emphysema model ( | Not evaluated | Histopathology | Inhibited emphysema-like features when treated with LY | Lycopene acts as an antioxidant and anti-inflammatory through the neutralization of reactive species production in vitro and in vivo, the restoration of the GSH/GSSG ratio, decreasing oxidative damage, decreasing pro-inflammatory cytokines through decreased cell influx and the direct suppression of cytokine production. | Campos et al. (2017) [ |
| Cigarette smoke exposure 3 times a day for 60 days | SOD/CAT/GPxGSH/GSSG ratio | ↔SOD/↓CAT/↑GPx | ||||
| Treatment with lycopene (LY) diluted in sunflower oil (25 and 50 mg/kg/day) | TBARS | ↓TBARS | ||||
| IFN-γ/TNF-α/IL-10 (bronchoalveolar fluid) | ↓ IFN-γ/TNF-α/IL-10 | |||||
| Leukocyte influx (bronchoalveolar fluid) | ↓ Leukocyte influx |